Plaquenil is a brand name of hydroxychloroquine, approved by the FDA in the following formulation(s):
PLAQUENIL (hydroxychloroquine sulfate - tablet; oral)
Manufacturer: SANOFI AVENTIS US
Approved Prior to Jan 1, 1982
Strength(s): 200MG [RLD][AB]
Has a generic version of Plaquenil been approved?
Yes. The following products are equivalent to Plaquenil:
hydroxychloroquine sulfate tablet; oral
Manufacturer: IPCA LABS LTD
Approval date: June 14, 2007
Strength(s): 200MG [AB]
Manufacturer: MYLAN
Approval date: May 29, 1998
Strength(s): 200MG [AB]
Manufacturer: SANDOZ
Approval date: November 30, 1995
Strength(s): 200MG [AB]
Manufacturer: SANDOZ
Approval date: January 27, 1996
Strength(s): 200MG [AB]
Manufacturer: TEVA PHARMS
Approval date: September 30, 1994
Strength(s): 200MG [AB]
Manufacturer: WATSON LABS
Approval date: November 30, 1995
Strength(s): 200MG [AB]
Manufacturer: WEST WARD
Approval date: August 15, 2007
Strength(s): 200MG [AB]
Manufacturer: ZYDUS PHARMS USA INC
Approval date: September 21, 2007
Strength(s): 200MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Plaquenil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Plaquenil.
See also...
- Plaquenil Consumer Information (Drugs.com)
- Plaquenil Consumer Information (Wolters Kluwer)
- Plaquenil Sulfate Consumer Information (Cerner Multum)
- Plaquenil Advanced Consumer Information (Micromedex)
- Plaquenil AHFS DI Monographs (ASHP)
- Hydroxychloroquine Consumer Information (Wolters Kluwer)
- Hydroxychloroquine Consumer Information (Cerner Multum)
- Hydroxychloroquine Advanced Consumer Information (Micromedex)
- Hydroxychloroquine Sulfate AHFS DI Monographs (ASHP)
No comments:
Post a Comment